Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone for asymptomatic moderate or severe aortic stenosis
ACTRN12606000125527Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jun 2003
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in aortic stenosis (AS) comparing Eplerenone with Placebo (2 arms). Primary endpoint: Change in left ventricular mass and volumes measured by magnetic resonance imaging. Started Jun 2003; status: completed.
02
Drugs
eplerenone
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on ACTRN12606000125527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000125527.